Karuna Therapeutics Inc. (KRTX)
NASDAQ: KRTX
· Real-Time Price · USD
329.83
0.09 (0.03%)
At close: Mar 15, 2024, 9:00 PM
Karuna Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -113.82M | -119.12M | -103.16M | -97.57M | -76.21M | -76.96M | -64.94M | -58.22M | -27.96M | -50.93M | -34.42M | -30.5M |
Depreciation & Amortization | 447K | 458K | 469K | 327K | 305K | 290K | 269K | 248K | 236K | 106K | 52K | 112K |
Stock-Based Compensation | 22.79M | 18.3M | 18M | 15.51M | 12.66M | 12.02M | 12.13M | 10.64M | 8.32M | 8.2M | 7.47M | 5.82M |
Other Working Capital | -14.01M | -444K | 29.32M | 1.85M | 2.68M | -10.98M | 15.17M | -4.02M | 13.74M | -1.4M | -2.98M | 2.16M |
Other Non-Cash Items | -122.91M | -10.91M | 103.16M | -7.3M | -4.68M | -790K | 178K | 285K | 353K | 312K | 202K | 898K |
Deferred Income Tax | 112.51M | n/a | -112.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -10.08M | 1.28M | 29.91M | -11.58M | -10.83M | 5.5M | 12.86M | -2.75M | 12.05M | -1.5M | -2.2M | 2.49M |
Operating Cash Flow | -111.06M | -110M | -64.13M | -100.63M | -78.76M | -59.95M | -39.5M | -49.8M | -7M | -43.81M | -28.89M | -21.18M |
Capital Expenditures | -799K | -629K | -775K | -714K | -290K | -174K | -451K | 206K | -769K | -1.52M | -739K | -47K |
Cash Acquisitions | -847K | -28.94M | 252.81M | 847K | 1.22M | 291.85M | n/a | n/a | 3.15M | n/a | n/a | 66K |
Purchase of Investments | -226.19M | -367.86M | -605.8M | -320.68M | -470.93M | -368.85M | -42.2M | -48.3M | -111.33M | -99.05M | -109.59M | -80.86M |
Sales Maturities Of Investments | 319.43M | 396.8M | 353M | 293.9M | 164.6M | 77M | 37.1M | 66.1M | 70.07M | 50.2M | 128.94M | 132M |
Other Investing Acitivies | 847K | 28.94M | -252.81M | -847K | -1.22M | -291.85M | -5.1M | -206K | -3.15M | n/a | n/a | -66K |
Investing Cash Flow | 92.44M | 28.31M | -253.58M | -27.49M | -306.62M | -292.02M | -5.55M | 17.8M | -42.02M | -50.37M | 18.6M | 51.1M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 19.87M | 2.66M | 18.4M | 442.45M | 5.38M | 844.19M | 4.95M | 1.26M | 3.75M | 749K | 2.25M | 270.82M |
Financial Cash Flow | 19.87M | 2.66M | 18.4M | 442.45M | 5.38M | 844.19M | 4.95M | 1.26M | 3.75M | 749K | 2.25M | 270.82M |
Net Cash Flow | 1.25M | -79.03M | -299.32M | 314.33M | -379.99M | 492.22M | -40.11M | -30.75M | -45.27M | -93.43M | -8.04M | 300.74M |
Free Cash Flow | -111.86M | -110.63M | -64.91M | -101.34M | -79.05M | -60.12M | -39.95M | -49.6M | -7.77M | -45.33M | -29.63M | -21.23M |